HAVING taken a back seat in 2022 due to more urgent global priorities such as the Russia-Ukraine war, Quad — the four-nation group of India, Japan, Australia and the US — found its work cut out last week. Fiji, where ethnic Indians were in a majority until the aftermath of a military cou
Mediclinic Welcare Hospital has become the first hospital in the MENA region to offer iTind – an advanced and minimally invasive procedure for the enlarged prostate.
Urethral stricture disease is relatively common and is associated with a significant financial cost and potentially debilitating outcomes. Strictures can occur anyt.
Optilume is a novel treatment for urethral strictures because it directly treats the strictured urethra and gets rid of fibrous tissue causing it. It can reduce the rate of stricture recurrence and the need for retreatment and reduce the need for urethroplasty, a more invasive procedure. The minimally invasive procedure reduces operating and recovery time and is likely to have lower risks compared with more invasive treatments. It does not require an overnight stay. All in all, Optilume has the potential to replace urethroplasty for strictures.
As part of Mediclinic’s vision to implement the most innovative technologies for better patient care, Dr Salam Alhasani, Consultant Urological Surgeon and Clinical Professor, and the Urology team at Mediclinic Welcare Hospital performed a highly successful Optilume procedure last week. Mediclinic Welcare Hospital took the lead to perform the first procedure in the UAE and the wider region.